Pancreatic Cancer Research

ResearcherShandong UniversityNo recent work listed

Chengkun Qin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5057-2443; OpenAlex author ID A5037909273. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 7

  1. Corrigendum to "Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1" [Canc. Le… Co-author DOI 10.1016/j.canlet.2022.215739↗
  2. [Corrigendum] Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma. Last author DOI 10.3892/ijo.2020.5157↗
  3. LncRNA TP73-AS1 sponges miR-141-3p to promote the migration and invasion of pancreatic cancer cells through the up-regulation of BDH2. Last author DOI 10.1042/bsr20181937↗
  4. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis. Co-author DOI 10.1016/j.canlet.2016.11.006↗
  5. Novel crosstalk between KLF4 and ZEB1 regulates gemcitabine resistance in pancreatic ductal adenocarcinoma. Last author DOI 10.3892/ijo.2017.4099↗
  6. Knockdown of GPR137 by RNAi inhibits pancreatic cancer cell growth and induces apoptosis. Last author DOI 10.1002/bab.1326↗
  7. HOXA10 promotes cell invasion and MMP-3 expression via TGFβ2-mediated activation of the p38 MAPK pathway in pancreatic cancer cells. First author DOI 10.1007/s10620-014-3033-6↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guozhe Xian · 5 shared papers, 2015–2022 · strength 0.54
  2. Zhenhai Zhang · 5 shared papers, 2014–2022 · strength 0.53
  3. Xianping Cui · 5 shared papers, 2014–2021 · strength 0.42
  4. Zhiyi Wang · 3 shared papers, 2017–2021 · strength 0.32
  5. Zhongxue Su · 3 shared papers, 2014–2022 · strength 0.32
  6. Xinxing Wang · 2 shared papers, 2017–2021 · strength 0.21
  7. Jian Li · 1 shared paper, 2019 · strength 0.11
  8. Xingsong Tian · 2 shared papers, 2014–2015 · strength 0.10
  9. Xin Liu · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.